Countrygirl
Senior Member
- Messages
- 5,652
- Location
- UK
There is no "umbrella" term for all of these illnesses.
That is a great idea Trish I agree, I think in this country and the way that things operate here, the Countess of Mar may be more effective with the powers that be than David Tuller.Is the Countess of Mar aware of this epidemic of nonsense spreading around the country?
I think of the splendid letter she wrote to the BBC. I wonder whether she could write a letter to the chief medical officer, the head of mental health in the NHS, the head of the NHS, NICE, all the clinical commissioning groups in the country etc. Any letter could be signed by as many medical people and ME charities as can be gathered to add clout.
Much as I appreciate David Tuller's skills, I think any letter or other approach needs to come from someone with a senior position within the UK, otherwise the powers that be will simply ignore it.
Once such a letter is in circulation, we can then do our best to raise awareness of it, and use it as ammunition in our own individual situations, for example contacting our local clinical commissioning groups and gp practices to alert them to the fact that this junk they are having foisted on them is not evidence based or effective for ME.
Ah well then, it shouldn't be.The term "functional somatic syndromes" has been in use as an umbrella term for a collection of conditions and illnesses since before 1999, in the US, UK and in other countries.
So that's just about got everyone on the entire planet covered to justify their interfering psych experiments,( clever marketing ) except them of course, they would never come under the category of Functional disorders or syndromes, any physical symptoms would of course be realrritable bowel syndrome, Chronic fatigue syndrome, Fibromyalgia, Multiple chemical sensitivity, Nonspecific chest pain, Premenstrual disorder, Non-ulcer dyspepsia, Repetitive strain injury, Tension headache, Temporomandibular joint disorder, Atypical facial pain, Hyperventilation syndrome, Globus syndrome, Sick building syndrome, Chronic pelvic pain, Chronic whiplash syndrome, Chronic Lyme disease, Silicone breast implant effects, Candidiasis hypersensivity, Food allergy, Gulf War syndrome, Mitral valve prolapse, Hypoglycemia, Chronic low back pain, Dizziness, Interstitial cystitis, Tinnitus, Pseudoseizures, Insomnia, Systemic yeast infection, Total allergy syndrome.
Maybe we could write a letter to the Countess and to the Forward ME group to ask them whether they are prepared to act on this.
We are not the only ones; there is a petition here
http://forums.phoenixrising.me/index.php?threads/me-is-not-mups-take-a-minute-to-sign-please.44475/
there are several other threads on MUPs too.
Maybe an email to our friend Kelvin Hopkins in the H of C.?
And/Or a petition of our own?
All ME charities/groups appear not to be doing anything (?); which given the whole PACE thing is confusing as this is confirming the very things all have supposedly been campaigning against ie no more CBT/GET for ME/CFS patients, and ME is a biological disease.
so fed up/tired of fighting for everything![]()
Now Im beggining to understand the enormity of this. No wonder the BPS crowd arent accepting the pushback on PACE there is a massive house of cards built on top of it.
Yes, and the next tranche of government investment in integrated IAPT delivered CBT for MUS and CFS is a gift which Prof Rona Moss-Morris (National Clinical Advisor to IAPT NHS England on MUS) and her colleagues will cherish and exploit.
Perhaps MEA might consider printing some nice purple Tee shirts with
"JUST SAY NO"
on them to wear when visiting GPs in those areas where services have already been rolled out and for when the next batch of areas have secured successful bids for funding to commission services.
OK. I think I've now posted pretty much all the material I have on this issue. I'll be flagging this thread up on Twitter over the coming week.
I closed my Dx Revision Watch Facebook page several years ago - so I don't have a presence on FB. But it would be useful if those who are on FB could give this thread some exposure. Also, the call for input from anyone who has already been offered referrals for CBT via IAPT services in their area, or for IAPT CBT via their GP (see Post #1).
Suzy
Thanks again for highlighting all this Suzy.
There is some good news, in N Ireland.
See @Keela Too post on I HAVE A HOPE FOR 2017 post re this
Thanks for the MUS link @medfeb . Once I've translated some of the 'social jargon' it could be v useful.
So it is not about if these treatments help or are effective in any way but purely about costs and trying to stop people with these illnesses going to the doctors or being referred to hospital specialists, because we are all undeserving and we waste the resources of the health service and are such a burdon.Via Dr Marc-Alexander Fluks:
Source: Journal of Psychosomatic Research
Preprint
Date: January 10, 2017
URL: http://www.sciencedirect.com/science/article/pii/S0022399917300181
Long-term economic evaluation of cognitive-behavioural group treatment
versus enhanced usual care for functional somatic syndromes
----------------------------------------------------------------------
Andreas Schroder(a,*), Eva Ornbol(a), Jens S. Jensen(a), Michael
Sharpe (b), Per Fink(a)
a Research Clinic for Functional Disorders and Psychosomatics, Aarhus
University Hospital, Aarhus, Denmark
b Psychological Medicine Research, Department of Psychiatry,
University of Oxford, UK
* Corresponding aithor. The Research Clinic for Functional Disorders
and Psychosomatics, Aarhus University Hospital, Noerrebrogade 44,
8000 Aarhus C, Denmark.
Received 23 June 2016
Revised 5 January 2017
Accepted 7 January 2017
Available online 10 January
Abstract
Objective
Patients with functional somatic syndromes (FSS) such as fibromyalgia
and chronic fatigue syndrome have a poor outcome and can incur high
healthcare and societal costs. We aimed to compare the medium-term (16
months) cost-effectiveness and the long-term (40 months) economic
outcomes of a bespoke cognitive-behavioural group treatment (STreSS)
with that of enhanced usual care (EUC).
Methods
We obtained complete data on healthcare and indirect costs (i.e.
labour-marked-related and health-related benefits) from public
registries for 120 participants from a randomised controlled trial.
Costs were calculated as per capita public expenses in 2010 EU. QALYs
gained were estimated from the SF-6D. We conducted a medium-term
cost-effectiveness analysis and a long-term cost-minimization analysis
from both a healthcare (i.e. direct cost) and a societal (i.e. total
cost) perspective.
Results
In the medium term, the probability that STreSS was cost-effective at
thresholds of 25,000 to 35,000 EU per QALY was 93-95% from a healthcare
perspective, but only 50-55% from a societal perspective. In the long
term, however, STreSS was associated with increasing savings in indirect
costs, mainly due to a greater number of patients self-supporting. When
combined with stable long-term reductions in healthcare expenditures,
there were total cost savings of 7184 EU (95% CI 2271 to 12,096,
p=0.004) during the third year after treatment.
Conclusion
STreSS treatment costs an average of 1545 EU. This cost was more than
offset by subsequent savings in direct and indirect costs.
Implementation could both improve patient outcomes and reduce costs.
Keywords: Economic evaluation; Cost-effectiveness; Cognitive-behavioural
therapy; Functional somatic syndromes; Bodily distress syndrome;
Fibromyalgia; Chronic fatigue syndrome
--------
(c) 2017 Elsevier Inc.